Dissolution Profile of Ibuprofen Solid Dispersion Prepared with Cellulosic Polymers and Sugar by Fusion Method

Authors

  • Nadia Saffoon Marketing Strategy Department, Ziska Pharmaceuticals Ltd., Dhaka
  • Yeakuty Marzan Jhanker Department of Pharmacy, The University of Asia Pacific, Dhaka
  • Naz Hasan Huda Department of Pharmacy, Stamford University Bangladesh

DOI:

https://doi.org/10.3329/sjps.v4i1.8864

Keywords:

Ibuprofen, Solid dispersion, Fusion method, Dissolution rate.

Abstract

The purpose of this study was to prepare and characterize solid dispersions of the NSAID Ibuprofen with HPMC, HPC, icing sugar, dextrose, mannitol and lactose with the intention of improving its dissolution properties. The solid dispersions were prepared by the fusion method. Evaluation of the properties of the dispersions was performed using dissolution studies. The results obtained showed that the rate of dissolution of Ibuprofen was considerably improved when formulated in solid dispersions with HPMC and HPC. Solid dispersions with icing sugar, dextrose, mannitol and lactose showed drug retarding capability which may trigger more research in the intension of exploiting this feature to prepare sustained release dosage form.  

Key words: Ibuprofen; Solid dispersion; Fusion method; Dissolution rate.

DOI: http://dx.doi.org/10.3329/sjps.v4i1.8864

SJPS 2011; 4(1): 31-37

Downloads

Download data is not yet available.
Abstract
181
PDF
1466

Downloads

How to Cite

Saffoon, N., Jhanker, Y. M., & Huda, N. H. (2011). Dissolution Profile of Ibuprofen Solid Dispersion Prepared with Cellulosic Polymers and Sugar by Fusion Method. Stamford Journal of Pharmaceutical Sciences, 4(1), 31–37. https://doi.org/10.3329/sjps.v4i1.8864

Issue

Vol. 4 No. 1 (2011)

Section

Research Articles

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.